Athenex to provide corporate and financial update for the third quarter 2021, on november 4, 2021

Buffalo, n.y., oct. 22, 2021 (globe newswire) -- athenex (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the company will provide a corporate and financial update for the third quarter 2021, on thursday, november 4, 2021. athenex's management team will host a conference call and live audio webcast at 10:00 a.m. eastern time.
ATNX Ratings Summary
ATNX Quant Ranking